VTP 950
Alternative Names: COVID-2019 vaccine; COVID-2019 vaccine - University of Oxford/Barinthus Biotherapeutics; VTP-950Latest Information Update: 12 Dec 2023
At a glance
- Originator University of Oxford
- Class COVID-19 vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical COVID 2019 infections
Most Recent Events
- 31 Aug 2020 Vaccitech in-licenses technology patents from University of Oxford (Vaccitech website, August 2020)
- 27 Aug 2020 Vaccitech plans a phase I trial for COVID-2019 infections (Prevention) (Parenteral) in 2021
- 01 Aug 2020 Preclinical trials in COVID-2019 infections (Prevention) in United Kingdom (Parenteral) before August 2020